Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00148655 · ClinicalTrials.gov registry record · NA

Educational Interventions for Patients With DCIS

A NA study, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
120
Enrollment target

NCT00148655 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 120 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00148655, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether adding an educational intervention, in the form of a decision board, which outlines the risks and benefits of treatment options for DCIS, at the time of the first surgical consultation will improve decision making for women with DCIS.

Interventions

  • DEVICE Decision Board

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2003-05
Est. Completion 2006-08
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

What the Registry Record Tells You About NCT00148655

The ClinicalTrials.gov registry entry for NCT00148655 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Decision Board is the first listed.

NCT00148655 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00148655 about?

NCT00148655 is a clinical study titled "Educational Interventions for Patients With DCIS". The purpose of this study is to determine whether adding an educational intervention, in the form of a decision board, which outlines the risks and benefits of treatment options for DCIS, at the time of the first surgical consultation will improve decision making for women with DCIS.

What is the current status of trial NCT00148655?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2003-05. Estimated completion is 2006-08.

What interventions are being tested in trial NCT00148655?

The interventions under investigation include: Decision Board (DEVICE).

Who is sponsoring clinical trial NCT00148655?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.